Portugal INFARMED

Imfinzi (Durvalumab): Public funding evaluation report available; approval of prior assessment requests

Original title: Imfinzi (Durvalumab) | Relatórios de avaliação de financiamento público disponível na Infomed | Deferimento dos pedidos de avaliação prévia

INFARMED has approved prior assessment requests for Imfinzi (durvalumab) and published the public funding evaluation report.

Low obligation Product class Pharmaceuticals Market Access & Reimbursement Portugal ReimbursementPharmaceuticals

Data : 06/08/2026

Dates and deadlines

Applies from

2026-08-06

Read the official source ↗

Published by Portugal INFARMED. HealthSignal links to the original document; the summary above is extracted from the source text.